Reduced doses of emicizumab achieve good efficacy: Results from a national‐wide multicentre real‐world study in China

Reduced doses of emicizumab improve the affordability among patients in developing countries. However, the relationship between variant dose selection and efficacy in the real world of China is still unclear.